173 related articles for article (PubMed ID: 15140260)
1. Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.
Leung DW; Tompkins C; Brewer J; Ball A; Coon M; Morris V; Waggoner D; Singer JW
Mol Cancer; 2004 May; 3():15. PubMed ID: 15140260
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase Cδ-4 (PLCδ4).
de Miranda MC; Rodrigues MA; de Angelis Campos AC; Faria JAQA; Kunrath-Lima M; Mignery GA; Schechtman D; Goes AM; Nathanson MH; Gomes DA
J Biol Chem; 2019 Nov; 294(45):16650-16662. PubMed ID: 31537645
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta.
Keshamouni VG; Mattingly RR; Reddy KB
J Biol Chem; 2002 Jun; 277(25):22558-65. PubMed ID: 11960991
[TBL] [Abstract][Full Text] [Related]
4. Growth factor-induced promoter activation of murine phospholipase C delta4 gene.
Fukami K; Takenaka K; Nagano K; Takenawa T
Eur J Biochem; 2000 Jan; 267(1):28-36. PubMed ID: 10601847
[TBL] [Abstract][Full Text] [Related]
5. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
6. Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity.
Bjorkoy G; Perander M; Overvatn A; Johansen T
J Biol Chem; 1997 Apr; 272(17):11557-65. PubMed ID: 9111071
[TBL] [Abstract][Full Text] [Related]
7. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation.
Gaubert F; Escaffit F; Bertrand C; Korc M; Pradayrol L; Clemente F; Estival A
J Biol Chem; 2001 Jan; 276(2):1545-54. PubMed ID: 11031252
[TBL] [Abstract][Full Text] [Related]
8. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
9. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
[TBL] [Abstract][Full Text] [Related]
10. A novel phospholipase C delta4 (PLCdelta4) splice variant as a negative regulator of PLC.
Nagano K; Fukami K; Minagawa T; Watanabe Y; Ozaki C; Takenawa T
J Biol Chem; 1999 Jan; 274(5):2872-9. PubMed ID: 9915823
[TBL] [Abstract][Full Text] [Related]
11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation.
El Hiani Y; Ahidouch A; Lehen'kyi V; Hague F; Gouilleux F; Mentaverri R; Kamel S; Lassoued K; Brûlé G; Ouadid-Ahidouch H
Cell Physiol Biochem; 2009; 23(4-6):335-46. PubMed ID: 19471101
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.
Greco S; Muscella A; Elia MG; Salvatore P; Storelli C; Mazzotta A; Manca C; Marsigliante S
J Cell Physiol; 2003 Aug; 196(2):370-7. PubMed ID: 12811831
[TBL] [Abstract][Full Text] [Related]
16. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
18. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
19. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
20. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
Song X; Wei Z; Shaikh ZA
Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
